![]()
|
|
||||||||
J. Biol. Chem., Vol. 279, Issue 25, 26105-26114, June 18, 2004
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
in the Brain*



¶
From the
Bloomfield Center for Research in Aging, Lady Davis Institute for Medical Research, Sir Mortimer B. Davis-Jewish General Hospital and the
Department of Neurology and Neurosurgery, McGill University, Montreal, Quebec H3T 1E2, Canada
In mammalian brain, tau, glycogen synthase kinase 3
(GSK3
), and 14-3-3, a phosphoserine-binding protein, are parts of a multiprotein tau phosphorylation complex. Within the complex, 14-3-3 simultaneously binds to tau and GSK3
(Agarwal-Mawal, A., Qureshi, H. Y., Cafferty, P. W., Yuan, Z., Han, D., Lin, R., and Paudel, H. K. (2003) J. Biol. Chem. 278, 1272212728). The molecular mechanism by which 14-3-3 connects GSK3
to tau within the complex is not clear. In this study, we find that GSK3
within the tau phosphorylation complex is phosphorylated on Ser9. From extracts of rat brain and rat primary cultured neurons, Ser9-phosphorylated GSK3
precipitates with glutathione-agarose beads coated with glutathione S-transferase-14-3-3. Similarly, from rat brain extract, Ser9-phosphorylated GSK3
co-immunoprecipitates with tau. In vitro, 14-3-3 binds to GSK3
only when the kinase is phosphorylated on Ser9. In transfected HEK-293 cells, 14-3-3 binds to Ser9-phosphorylated GSK3
and does not bind to GSK3
(S9A). Tau, on the other hand, binds to both GSK3
(WT) and GSK3
(S9A). Moreover, 14-3-3 enhances the binding of tau with Ser9-phosphorylated GSK3
by
3-fold but not with GSK3
(S9A). Similarly, 14-3-3 stimulates phosphorylation of tau by Ser9-phosphorylated GSK3
but not by GSK3
(S9A). In transfected HEK-293 cells, Ser9 phosphorylation suppresses GSK3
-catalyzed tau phosphorylation in the absence of 14-3-3. In the presence of 14-3-3, however, Ser9-phosphorylated GSK3
remains active and phosphorylates tau. Our data indicate that within the tau phosphorylation complex, 14-3-3 connects Ser9-phosphorylated GSK3
to tau and Ser9-phosphorylated GSK3
phosphorylates tau.
Received for publication, July 30, 2003 , and in revised form, February 16, 2004.
* This work was supported by grants from the Canadian Institute of Health Research, the American Health Assistance Foundation, and the Alzheimer Society of Canada. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
¶ To whom all correspondence should be addressed: Bloomfield Center for Research in Aging, Lady Davis Institute for Medical Research, 3755 Cote Ste-Catherine, Montreal, Quebec H3T 1E2, Canada. Tel.: 514-340-8222 (ext. 4866); Fax: 514-340-8295; E-mail: hemant.paudel{at}mcgill.ca.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
T. J. Nelson and D. L. Alkon Protection against beta-Amyloid-induced Apoptosis by Peptides Interacting with beta-Amyloid J. Biol. Chem., October 26, 2007; 282(43): 31238 - 31249. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Alvarez, X. Altafaj, S. Aranda, and S. de la Luna DYRK1A Autophosphorylation on Serine Residue 520 Modulates Its Kinase Activity via 14-3-3 Binding Mol. Biol. Cell, April 1, 2007; 18(4): 1167 - 1178. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Avraham, R. Szargel, A. Eyal, R. Rott, and S. Engelender Glycogen Synthase Kinase 3beta Modulates Synphilin-1 Ubiquitylation and Cellular Inclusion Formation by SIAH: IMPLICATIONS FOR PROTEASOMAL FUNCTION AND LEWY BODY FORMATION J. Biol. Chem., December 30, 2005; 280(52): 42877 - 42886. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Tan, L. Zhuang, H.-S. Leong, N. G. Iyer, E. T. Liu, and Q. Yu Pharmacologic Modulation of Glycogen Synthase Kinase-3{beta} Promotes p53-Dependent Apoptosis through a Direct Bax-Mediated Mitochondrial Pathway in Colorectal Cancer Cells Cancer Res., October 1, 2005; 65(19): 9012 - 9020. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. L. Lambourne, L. A. Sellers, T. G. Bush, S. K. Choudhury, P. C. Emson, Y.-H. Suh, and L. S. Wilkinson Increased tau Phosphorylation on Mitogen-Activated Protein Kinase Consensus Sites and Cognitive Decline in Transgenic Models for Alzheimer's Disease and FTDP-17: Evidence for Distinct Molecular Processes Underlying tau Abnormalities Mol. Cell. Biol., January 1, 2005; 25(1): 278 - 293. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |